Jacaranda FM·3 min read·medium
Trial of potential Ebola antiviral under way: WHO
✦AI Summary
The WHO has launched the first clinical trial for an experimental antiviral drug, obeldesivir, to treat individuals exposed to the Bundibugyo Ebola strain in the Democratic Republic of Congo. The trial aims to recruit 1,000 participants to test the drug's effectiveness as a post-exposure preventative measure.
Updated July 15, 2026, 7:01 a.m. | By AFP
healthscienceworld
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in